TORONTO, May 9, 2022
/CNW/ - Steve Saviuk, Chief
Executive Officer, Frederic Fasano,
President and Chief Operating Officer, Luc
Mainville, Senior Vice-President and Chief Financial
Officer, Valeo Pharma Inc. ("Valeo" or the "Company") (TSX: VPH)
and their team joined Daniel Lubienietzky, Manager, Life Sciences,
Toronto Stock Exchange, to celebrate the Company's new listing on
Toronto Stock Exchange and open the market.
Headquartered in Kirkland,
Quebec, Valeo Pharma is a Canadian specialty pharmaceutical
company dedicated to the commercialization of innovative
prescription products in Canada,
with a focus on respirology, neurodegenerative diseases, oncology
and other specialty products.
Date: Monday, May
9, 2022
Time:
9:00am - 9:30am
Place: 120
Adelaide St W.
SOURCE Toronto Stock Exchange